UPLOAD Filing
Matinas BioPharma Holdings, Inc.
Date: April 28, 2025 · CIK: 0001582554 · Accession: 0000000000-25-004450
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286686
Letter
Re: Matinas BioPharma Holdings, Inc. Registration Statement on Form S-3 Filed April 22, 2025 File No. 333-286686 Dear Jerome D. Jabbour:
April 28, 2025
Jerome D. Jabbour Chief Executive Officer Matinas BioPharma Holdings, Inc. 1545 Route 206 South, Suite 302 Bedminster, New Jersey 07921
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Steven M. Skolnick, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 28, 2025 Jerome D. Jabbour Chief Executive Officer Matinas BioPharma Holdings, Inc. 1545 Route 206 South, Suite 302 Bedminster, New Jersey 07921 Re: Matinas BioPharma Holdings, Inc. Registration Statement on Form S-3 Filed April 22, 2025 File No. 333-286686 Dear Jerome D. Jabbour: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Skolnick, Esq. </TEXT> </DOCUMENT>